US 9394323
Antisense antiviral compound and method for treating influenza viral infection
granted A61KA61K31/165A61K31/43
Quick answer
US patent 9394323 (Antisense antiviral compound and method for treating influenza viral infection) held by Sarepta Therapeutics, Inc. expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/165, A61K31/43, A61K31/5377, A61K31/545